How to Vet an Exosome Supplier: 7 Questions Every Physician Should Ask
The exosome market is crowded, and quality varies widely. If you are sourcing MSC-derived exosomes for research, the supplier you choose matters as much as the material. This is a practical, research-use-only vetting guide — it makes no treatment or efficacy claims, and it is not legal advice.
Why supplier vetting matters
Because exosome composition depends entirely on source cells and manufacturing, two products labeled “exosomes” can be very different. The only way to know what you are getting is documentation. Below are seven questions that separate credible suppliers from the rest.
The 7 questions
1. Can you provide a Certificate of Analysis for every lot?
A per-lot CoA is the baseline. If a supplier cannot produce one, stop there.
2. How is the material characterized?
Look for particle size and concentration (e.g., nanoparticle tracking analysis) and identity markers consistent with extracellular vesicles — not just a product name.
3. What sterility and endotoxin testing is performed?
Sterility and endotoxin screening should be documented for each lot.
4. What is the source and is the donor traceable?
The MSC source (e.g., Wharton’s jelly) and donor screening/traceability should be disclosed.
5. Is the material clearly labeled research use only?
Credible suppliers label material RUO and avoid disease-treatment claims. Aggressive efficacy marketing is a red flag, not a selling point.
6. Does the supplier make treatment or “cure” claims?
They should not. No exosome product is FDA-approved to treat disease; a supplier promising outcomes is a warning sign.
7. Can they point to published research rather than testimonials?
Credible suppliers reference the peer-reviewed literature, not before/after marketing.
Red flags at a glance
- No Certificate of Analysis
- No characterization or sterility/endotoxin data
- Disease-treatment or “cure” claims
- “FDA-registered” presented as if it were FDA approval
- Testimonials in place of published research
Where to verify the science
Ask any supplier to back claims with primary literature. We maintain an open, indexed MSC Exosome Research Library so the research is transparent and checkable.
Frequently Asked Questions
What should I ask an exosome supplier?
At minimum: per-lot Certificate of Analysis, characterization data, sterility/endotoxin testing, donor traceability, RUO labeling, and published research rather than testimonials.
Are any exosome suppliers FDA-approved?
No exosome product is FDA-approved for therapeutic use. Credible suppliers provide research-use-only material and avoid treatment claims.
What is the biggest red flag?
A supplier that cannot document what is in the vial, or that markets exosomes as a treatment or cure for a disease.
These statements have not been evaluated by the FDA. BioRegenEx supplies MSC-derived exosomes for research use only (RUO); they are not intended to diagnose, treat, cure, or prevent any disease. This content is educational and is not medical or legal advice.